A San Diego-based specialty pharmaceutical company aimed at reformulation of an existing COPD drugs, delivered in a nebulized format. Mesa Verde lead a convertible note financing at a discount into the Series A round of $30 million led by Canaan Partners. In September 2012, Elevation was acquired for up to $430 million by Sunovian.